154 related articles for article (PubMed ID: 9422095)
1. Specificity clusters of MUC1-reactive mouse monoclonal antibodies.
Hanisch FG
Tumour Biol; 1998; 19 Suppl 1():111-7. PubMed ID: 9422095
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
3. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
Reis CA; Hassan H; Bennett EP; Clausen H
Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098
[TBL] [Abstract][Full Text] [Related]
5. Epitope characterization of MUC1 antibodies.
Blockzjil A; Nilsson K; Nilsson O
Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
[TBL] [Abstract][Full Text] [Related]
7. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
[TBL] [Abstract][Full Text] [Related]
8. Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas.
Baldus SE; Goergen D; Hanisch FG; Dienes HP
Int J Oncol; 2001 Mar; 18(3):507-12. PubMed ID: 11179479
[TBL] [Abstract][Full Text] [Related]
9. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence.
Schol DJ; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Murakami F; Kenemans P; Hilgers J
Tumour Biol; 1998; 19 Suppl 1():35-45. PubMed ID: 9422087
[TBL] [Abstract][Full Text] [Related]
10. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.
Zhou D; Xu L; Huang W; Tonn T
Molecules; 2018 May; 23(6):. PubMed ID: 29857542
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
[TBL] [Abstract][Full Text] [Related]
12. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the carbohydrate specificity of ISOBM TD-4 Workshop anti-MUC1 antibodies.
Lloyd KO; Kudryashov V
Tumour Biol; 1998; 19 Suppl 1():118-21. PubMed ID: 9422096
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
Petrakou E; Murray A; Price MR
Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
16. MUC1 glycopeptide epitopes predicted by computational glycomics.
Song W; Delyria ES; Chen J; Huang W; Lee JS; Mittendorf EA; Ibrahim N; Radvanyi LG; Li Y; Lu H; Xu H; Shi Y; Wang LX; Ross JA; Rodrigues SP; Almeida IC; Yang X; Qu J; Schocker NS; Michael K; Zhou D
Int J Oncol; 2012 Dec; 41(6):1977-84. PubMed ID: 23023583
[TBL] [Abstract][Full Text] [Related]
17. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
Karsten U; Serttas N; Paulsen H; Danielczyk A; Goletz S
Glycobiology; 2004 Aug; 14(8):681-92. PubMed ID: 15115750
[TBL] [Abstract][Full Text] [Related]
18. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
Dai J; Allard WJ; Davis G; Yeung KK
Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
[TBL] [Abstract][Full Text] [Related]
19. Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope.
Singh J; Her C; Supekar N; Boons GJ; Krishnan VV; Brooks CL
J Pept Sci; 2020 Jan; 26(1):e3229. PubMed ID: 31729101
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.
Ryan SO; Vlad AM; Islam K; Gariépy J; Finn OJ
Biol Chem; 2009 Jul; 390(7):611-8. PubMed ID: 19426130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
